3D Systems Announces Formation of New Biotech Company, Systemic Bio™, to Accelerate Drug Discovery and Development
More than 35 years ago, 3D Systems brought the innovation of 3D printing to the manufacturing industry. Today, as the leading additive manufacturing solutions partner, we bring innovation, performance, and reliability to every interaction - empowering our customers to create products and business models never before possible. Thanks to our unique offering of hardware, software, materials, and services, each application-specific solution is powered by the expertise of our application engineers who collaborate with customers to transform how they deliver their products and services. 3D Systems’ solutions address a variety of advanced applications in healthcare and industrial markets such as medical and dental, aerospace & defense, automotive, and durable goods. More information on the company is available at
www.3dsystems.com.
Investor Contact:
investor.relations@3dsystems.com
Media Contact:
press@3dsystems.com
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/61289c73-0c37-429e-9ec0-5e9f5fffc059
https://www.globenewswire.com/NewsRoom/AttachmentNg/2ca965db-aaf0-417e-adb8-ea03a9490944
h-VIOS2
h-VIOS2 containing two perfused vascularized hydrogels. Within this chip’s footprint, any vasculature can be created.
Taci Pereira
Taci Pereira named CEO of Systemic Bio.